Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for PAIOF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
December 31, 2015 38.63M
September 30, 2015 48.11M
June 30, 2015 58.11M
March 31, 2015 62.81M
December 31, 2014 75.76M
September 30, 2014 82.41M
June 30, 2014 28.15M
March 31, 2014 30.21M
December 31, 2013 18.37M
September 30, 2013 16.21M
June 30, 2013 17.19M
March 31, 2013 18.99M
December 31, 2012 20.53M
September 30, 2012 19.93M
June 30, 2012 19.69M
March 31, 2012 23.16M
December 31, 2011 -0.6023M
September 30, 2011 10.38M
June 30, 2011 13.68M
March 31, 2011 14.06M
December 31, 2010 16.06M
September 30, 2010 17.17M
June 30, 2010 19.57M
March 31, 2010 22.33M
Date Value
December 31, 2009 27.70M
September 30, 2009 32.28M
June 30, 2009 36.39M
March 31, 2009 37.97M
December 31, 2008 43.83M
September 30, 2008 51.78M
June 30, 2008 61.68M
March 31, 2008 54.78M
December 31, 2007 52.14M
September 30, 2007 55.96M
June 30, 2007 47.24M
March 31, 2007 55.30M
December 31, 2006 59.96M
September 30, 2006 63.05M
June 30, 2006 65.84M
March 31, 2006 57.78M
December 31, 2005 62.22M
September 30, 2005 70.32M
June 30, 2005 59.62M
March 31, 2005 68.77M
December 31, 2004
September 30, 2004 29.50M
June 30, 2004 32.35M
March 31, 2004 7.699M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
CureVac NV 1.024B
Anbio Biotechnology --
Epigenomics AG --
ACADIA Pharmaceuticals, Inc. 1.307B
Alkermes Plc 1.809B